The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
among universities worldwide for producing undergrad entrepreneurs
companies founded by graduates and faculty in the last 10 years
in Europe and #21 in the world for aerospace engineering*
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSAs seen on ISRAEL21c.
Machine-learning analysis of CT scans during admission to the emergency enables earlier detection of intracerebral hemorrhages and reduces mortality rate by over 30 percent, according to a study published in the International Journal of Emergency Medicine (opens in a new tab).
Intracerebral hemorrhage, commonly known as bleeding into the brain, is the second most common cause of strokes (15-30%) and the most deadly.
The research, conducted by Dr. David Orion, director of the Acute Stroke & Neuro-Endovascular Department of Sheba Medical Center (opens in a new tab) in Israel, involved 587 patients and used Aidoc (opens in a new tab)’s algorithm to analyze CT scans of their heads.
Aidoc is a medical technology company that creates AI solutions for clinical usage. Aidoc CEO Elad Walach is a Technion alumnus.
by
archive.israel21c.org (opens in a new tab)
on
September 27, 2023
Discover the impact of automated CT analysis in emergencies, cutting mortality from brain hemorrhages by over 30 percent.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
AI / Alumni / Biotech / Neurological Diseases /
The Nobel Assembly at Karolinska Institutet announced Monday that professors Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Medicine, with two of the three laureates having received the Technion-Israel Institute of Technology Harvey Prize. Prof. Deisseroth of the Howard Hughes Medical Institute and Stanford University, USA, and Prof. Hegemann […]
A breast cancer diagnosis can bring a terrifying question: Will chemotherapy save my life, or will I endure its painful side effects without any benefit? In this video, influencer Aija Mayrock goes inside the Technion – Israel Institute of Technology with Dr. Gil Shamai to explore an AI breakthrough that could help doctors answer that […]
A Breakthrough From the Technion Together with collaborators from leading medical centers in Israel, the United States, Europe, and Australia, Shamai and his team at the Technion have developed an AI model that predicts both the risk that breast cancer will return and whether a patient is likely to benefit from chemotherapy — offering a […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.